BioCatalystWatch
EVMNWorkspace / EVMN / OverviewCompany library
Price
Market cap
Next catalystJanuary 2027 — China Phase 1EVO570 — planned Phase 1 clinical development · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

EVO756

Small molecule

MRGPRX2

PreINDP1P2P3FilingApproved
Upcoming / outlook

EVO756

Small molecule

MRGPRX2

Upcoming / outlook

EVO646

TLR7 × TLR8

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO301

IL-18 × Human serum albumin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO301

IL-18 × Human serum albumin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO570

VAV1 × CRBN

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

EVO570

VAV1 × CRBN

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO301

IL-18 × Human serum albumin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO646

TLR7 × TLR8

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EVO756

Small molecule

MRGPRX2

Upcoming / outlook

EVO756

Small molecule

MRGPRX2

PreINDP1P2P3FilingApproved
Upcoming / outlook

EVO301

IL-18 × Human serum albumin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

EVO101

Small molecule

IRAK4

PreINDP1P2P3FilingApproved

History / paused

EVO756

Small molecule

MRGPRX2

PreINDP1P2P3FilingApproved
EVO756

Small molecule

MRGPRX2

PreINDP1P2P3FilingApproved
EVO756

Small molecule

MRGPRX2

PreINDP1P2P3FilingApproved
EVO301

IL-18 × Human serum albumin

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

EVMN PR & News

PR & News

EVMN SEC archive